section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in both dextrose 5% and sodium chloride 0.9%.

d Tested in dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

e Tested in both Ringer’s injection, lactated and sodium chloride 0.9%.

f Refer to Appendix for the composition of parenteral nutrition solutions. TPN indicates a 2-in-1 admixture.

g Tested with heparin sodium (Riker) 1000 units/L.

h Tested in sterile water for injection.

i Tested with hydrocortisone sodium succinate (Upjohn) 100 mg/L.

j Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

k Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

l Test performed using the formulation WITH edetate disodium.

m Salt not specified.

n Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

o Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.